Preparation and evaluation of inhalable itraconazole chitosan based polymeric micelles

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Moazeni, Esmaeil ^a   Gilani, Kambiz ^a   Najafabadi, Abdolhossein Rouholamini ^a   Reza Rouini, Mohamad ^a   Mohajel, Nasir ^a   Amini, Mohsen ^a   Barghi, Mohammad Ali ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Chitosan; Itraconazole; Nebulization; Polymeric micelles; Pulmonary drug delivery

Indexed keywords

CHITOSAN DERIVATIVE; ITRACONAZOLE; NANOCARRIER; STEARIC ACID;

ARTICLE; CHEMICAL STRUCTURE; CRITICAL MICELLE CONCENTRATION; DYNAMIC LIGHT SCATTERING; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84872351463     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-85     Document Type: Article

References (32)

1. Invasive aspergillosis, Clinical infectious disease. Denning DW, Chest 1998 26 781 803
2. Diagnosis of invasive mycoses in severely immunosuppressed patients. Ruchel R, Ann Hematol 1993 67 1 11 10.1007/BF01709659 8334194 (Pubitemid 23231379)
3. Suitability of Caspofungin for Aerosol Delivery Physicochemical Profiling and Nebulizer Choice. Wong-Beringer A, Lambros MP, Beringer PM, Johnson DL, Chest 2005 128 3711 3716 10.1378/chest.128.5.3711 16304338 (Pubitemid 41698718)
4. Itraconazole for Experimental Pulmonary Aspergillosis: Comparison with Amphotericin B, Interaction with Cyclosporin A, and Correlation between Therapeutic Response and Itraconazole Concentrations in Plasma. Berenguer J, Ali NM, Allende MC, Lee J, Garrett K, Battaglia S, Piscitelli SC, Rinaldi MG, Pizzo PA, Walsh TJ, Antimicrob Agents Chemother 1994 38 1303 1308 10.1128/AAC.38.6.1303 8092829 (Pubitemid 24170711)
5. Characterization of the interaction of 2-hydroxypropyl-ß- cyclodextrin with Itraconazole at pH 2, 4, and 7. Peeters J, Neeskens P, Tollenaere JP, Remoortere PV, Brewster ME, J Pharm Sci 2002 91 1414 1422 10.1002/jps.10126 12115841 (Pubitemid 34633957)
6. Pharmacokinetics and Safety of a 7-Day Administration of Intravenous Itraconazole followed by a 14-Day Administration of Itraconazole Oral Solution in Patients with Hematologic Malignancy. Boogaerts MA, Maertens J, Gees RVD, Bosly A, Michaux JL, Hoof AV, Cleeren M, Wostenborghs R, Beule KD, Antimicrob Agents Chemother 2001 45 981 985 10.1128/AAC.45.3.981-985.2001 11181397 (Pubitemid 32182062)
7. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Kipp JE, Int J Pharm 2004 284 109 122 10.1016/j.ijpharm.2004.07.019 15454302 (Pubitemid 39349144)
8. Intravenous itraconazole emulsions produced by SolEmuls technology. Akkar A, Muller RH, Eur J Pharm Biopharm 2003 56 29 36 10.1016/S0939-6411(03)00063-8 12837478 (Pubitemid 36802044)
9. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Keck CM, Muller RH, Eur J Pharm Biopharm 2006 62 3 16 10.1016/j.ejpb.2005.05.009 16129588 (Pubitemid 41736019)
10. Stabilizer choice for rapid dissolving high potency itraconazole particles formed by evaporative precipitation into aqueous solution. Sinswat P, Gao X, Yacaman MJ, Williams RO, Johnston KP, Int J Pharm 2005 302 113 124 10.1016/j.ijpharm.2005.06.027 16109466 (Pubitemid 41242757)
11. Targeted High Lung Concentrations of Itraconazole Using Nebulized Dispersions in a Murine Model. McConville JT, Overhoff KA, Sinswat P, Vaughn JM, Frei BL, Burgess DS, Talbert RL, Peters JI, Johnston KP, Williams RO, Pharm Res 2006 23 901 911 10.1007/s11095-006-9904-6 16715380 (Pubitemid 43781398)
12. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. Yang W, Tam J, Miller DA, Zhou J, McConville JT, Johnston KP, Williams RO, Int J Pharm 2008 361 177 188 10.1016/j.ijpharm. 2008.05.003 18556158
13. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Nishiyama N, Kataoka K, Pharmacol Ther 2006 112 630 648 10.1016/j.pharmthera.2006.05.006 16815554 (Pubitemid 44592613)
14. Chitosan and its use as a pharmaceutical excipient. Illum L, Pharm Res 1998 15 1326 1331 10.1023/A:1011929016601 9755881 (Pubitemid 28427917)
15. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Zhang J, Chen XG, Li Y, Liu CS, Nanomedicine 2007 3 258 265 10.1016/j.nano.2007.08.002 17962086 (Pubitemid 350192330)
16. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH, et al. J Control Rel 2008 127 208 218 10.1016/j.jconrel.2008.01.013
17. N-Phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles. Opanasopit P, Ngawhirunpat T, Rojanarata T, Choochottiros C, Chirachanchai S, Eur J Pharm Sci 2007 30 424 431 10.1016/j.ejps.2007.01.002 17307343 (Pubitemid 46436457)
18. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Hu FQ, Ren GF, Yuan H, Du YZ, Zeng S, Colloids Surf B 2006 50 97 103 10.1016/j.colsurfb.2006. 04.009 (Pubitemid 43946659)
19. Polymeric Micelles of PEG-PE as Carriers of All-Trans Retinoic Acid for Stability Improvement. Wichit A, Tangsumranjit A, Pitaksuteepong T, Waranuch, AAPS PharmSciTech 2012 13 336 343 10.1208/s12249-011-9749-0 22274760
20. Development of Respirable Nanomicelle Carriers for Delivery of Amphotericin B by Jet Nebulization. Gilani K, Moazeni E, Ramezanli T, Amini M, Fazeli MR, Jamalifar H, J Pharm Sci 2011 100 252 259 10.1002/jps.22274 20602350
21. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. Sahib M, Darwis Y, Peh K, Abdulameer S, Tan Y, Int J Nanomedicine 2011 6 2351 2356 22072872
22. The depolymerization of chitosan: effects on physicochemical and biological properties. Mao S, Shuai X, Unger F, Simon M, Bi D, Kissel T, Int J Pharm 2004 281 45 54 10.1016/j.ijpharm.2004.05.019 15288342 (Pubitemid 39024262)
23. Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin. Du YZ, et al. Colloids Surf B 2009 69 257 263 10.1016/j.colsurfb.2008.11.030
24. A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics. Yi Y, et al. J Control Rel 2007 117 59 67 10.1016/j.jconrel.2006.10.001 (Pubitemid 46161866)
25. Study of the depolymerization behavior of chitosan by hydrogen peroxide. Tian F, Liu Y, Hu K, Zhao B, Carbohydr Polym 2004 57 31 37 10.1016/j.carbpol. 2004.03.016
26. Preparation of polymeric micelles based on chitosan bearing a small amount of highly hydrophobic groups. Jiang GB, Quan D, Liao K, Wang H, Carbohydr Polym 2006 66 514 520 10.1016/j.carbpol.2006.04.008 (Pubitemid 44648321)
27. Preparation of chitosan self-aggregates as a gene delivery systems. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY, J Control Rel 1998 51 213 220 10.1016/S0168-3659(97)00173-9 (Pubitemid 28252873)
28. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Lavasanifar A, Samuel J, Kwon GS, Adv Drug Deliv Rev 2002 54 169 190 10.1016/S0169-409X(02)00015-7 11897144 (Pubitemid 34230440)
29. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5ß-cholanic acid. Kwon SK, Park JH, Chung H, Kwon IC, Jeong SY, Langmuir 2003 19 10188 10193 10.1021/la0350608
30. Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. Tam J, McConville J, Williams R, Johnston K, J Pharm Sci 2008 97 4915 4933 10.1002/jps.21367 18351641
31. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin. Ye YQ, Yang FL, Hu FQ, Du YZ, Yuan H, Yu HY, Int J Pharm 2008 352 294 301 10.1016/j.ijpharm.2007.10.035 18096336
32. Micelle formation and drug release behavior of polypeptide graft copolymer and its mixture with polypeptide block copolymer